BenzingaWed, 17 Jun 2026 16:43:03 GMTElicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer DrugBMY+0.49%
Zacks Investment ResearchWed, 17 Jun 2026 14:02:20 GMTInvestors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowBMY+0.49%
Zacks Investment ResearchTue, 16 Jun 2026 19:21:17 GMTCan BMY's Camzyos Strengthen Its Cardiovascular Portfolio?BMY+0.49%
24/7 Wall StreetMon, 15 Jun 2026 14:50:06 GMTA Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers SquibbBMY+0.49%
The Motley FoolSat, 13 Jun 2026 22:15:00 GMTHow Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.BMY+0.49%
Zacks Investment ResearchFri, 12 Jun 2026 18:20:31 GMTCan Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?BMY+0.49%
Zacks Investment ResearchThu, 11 Jun 2026 22:46:19 GMTWhy Bristol Myers Squibb (BMY) Outpaced the Stock Market TodayBMY+0.49%
The Motley FoolThu, 11 Jun 2026 18:02:00 GMTBristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.BMY+0.49%
Zacks Investment ResearchThu, 11 Jun 2026 14:40:33 GMTBristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?BMY+0.49%
Seeking AlphaWed, 10 Jun 2026 01:42:10 GMTBristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptBMY+0.49%
Zacks Investment ResearchFri, 05 Jun 2026 22:46:12 GMTBristol Myers Squibb (BMY) Gains As Market Dips: What You Should KnowBMY+0.49%
Zacks Investment ResearchThu, 04 Jun 2026 16:55:34 GMTArcus, Bristol Myers Team Up to Advance Kidney Cancer StudyBMY+0.49%
The Motley FoolThu, 04 Jun 2026 06:30:00 GMTBetter High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?BMY+0.49%
Zacks Investment ResearchWed, 03 Jun 2026 14:00:41 GMTBristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should KnowBMY+0.49%
The Motley FoolWed, 03 Jun 2026 07:45:00 GMTBristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?BMY+0.49%
Zacks Investment ResearchTue, 02 Jun 2026 18:01:14 GMTBMY Gets Opdivo Label Expansion in the EU, Update on CamzyosBMY+0.49%
Seeking AlphaTue, 02 Jun 2026 14:59:47 GMTBristol Myers Squibb: This Pullback Is A Gift For Long-Term InvestorsBMY+0.49%
Seeking AlphaTue, 02 Jun 2026 08:23:46 GMTBristol Myers' Growth Portfolio Just Overtook The Legacy OneBMY+0.49%
The Motley FoolTue, 02 Jun 2026 03:15:00 GMTWhy Bristol Myers Squibb Stock Isn't Nearly As Cheap As It LooksBMY+0.49%
